Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Cardiff Oncology, Inc.Listing on record | Buy | $993.2K | conv 42First in 12mo | SEC | |
RESPONSE GENETICS INCListing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
RESPONSE GENETICS INCListing on record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Cardiff Oncology, Inc.Listing on record | Buy | $1.2M | conv 11 | SEC | |
Cardiff Oncology, Inc.Listing on record | Buy | $2.1M | conv 21 | SEC | |
Cardiff Oncology, Inc.Listing on record | Buy | $2M | conv 46First in 12mo | SEC | |
Jazz Pharmaceuticals plcListing on record | Buy | $13.1K | conv 49Cluster | SEC | |
SYNAGEVA BIOPHARMA CORPListing unverified | Buy | $225.5K | conv 41ClusterFirst in 12mo | SEC |